Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene
- PMID: 26889255
- PMCID: PMC4727100
- DOI: 10.3892/etm.2015.2888
Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene
Abstract
The aim of the present study was to investigate the optimal mobilization plan in autologous peripheral blood stem cell transplantation for the treatment of diabetic foot and to observe its clinical curative effect. A total of 127 patients with diabetic foot were treated with different doses of granulocyte colony stimulating factor (G-CSF) to mobilize their hematopoietic stem cells. Subsequently, the extracted stem cell suspension was injected into the ischemic lower extremities along the blood vessels in the areas presenting with pathological changes. Following the treatment, the intermittent claudication distance, skin temperature, ankle brachial index and pain scores of the patients were evaluated. In addition, the associations among the mobilization time, doses and peripheral blood CD34+ level were analyzed. The collection efficiency of the stem cells was associated with the dose of G-CSF and the mobilization time. Following the injection of the autologous peripheral blood stem cell suspension, the ischemic area of the patients was improved significantly. In conclusion, autologous peripheral blood stem cell transplantation can promote the establishment of collateral circulation in patients with diabetic foot, and the optimal time for gathering stem cells is closely correlated with the peripheral blood CD34+ level.
Keywords: CD34+; autologous peripheral blood stem cells; diabetic foot; gangrene; stem cell mobilization.
Figures


Similar articles
-
[Autologous peripheral blood stem cells transplantation in treatment of 62 cases of lower extremity ischemic disorder].Zhonghua Nei Ke Za Zhi. 2005 Feb;44(2):95-8. Zhonghua Nei Ke Za Zhi. 2005. PMID: 15840218 Chinese.
-
Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor.Bone Marrow Transplant. 2006 Apr;37(7):661-8. doi: 10.1038/sj.bmt.1705304. Bone Marrow Transplant. 2006. PMID: 16489358 Clinical Trial.
-
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404. doi: 10.1016/j.bbmt.2004.02.001. Biol Blood Marrow Transplant. 2004. PMID: 15148493 Clinical Trial.
-
The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells.Cytokines Mol Ther. 1995 Dec;1(4):249-70. Cytokines Mol Ther. 1995. PMID: 9384679 Review.
-
Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells.Curr Opin Hematol. 2002 May;9(3):190-8. doi: 10.1097/00062752-200205000-00003. Curr Opin Hematol. 2002. PMID: 11953663 Review.
Cited by
-
Avoidance of Total Knee Arthroplasty in Early Osteoarthritis of the Knee with Intra-Articular Implantation of Autologous Activated Peripheral Blood Stem Cells versus Hyaluronic Acid: A Randomized Controlled Trial with Differential Effects of Growth Factor Addition.Stem Cells Int. 2017;2017:8925132. doi: 10.1155/2017/8925132. Epub 2017 Sep 19. Stem Cells Int. 2017. PMID: 29056974 Free PMC article.
-
Scorpion Venom Active Polypeptide May Be a New External Drug of Diabetic Ulcer.Evid Based Complement Alternat Med. 2017;2017:5161565. doi: 10.1155/2017/5161565. Epub 2017 Oct 29. Evid Based Complement Alternat Med. 2017. PMID: 29234410 Free PMC article.
-
The potential and limitations of induced pluripotent stem cells to achieve wound healing.Stem Cell Res Ther. 2019 Mar 12;10(1):87. doi: 10.1186/s13287-019-1185-1. Stem Cell Res Ther. 2019. PMID: 30867069 Free PMC article. Review.
-
Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association.Circulation. 2024 Jan 23;149(4):e232-e253. doi: 10.1161/CIR.0000000000001192. Epub 2023 Dec 14. Circulation. 2024. PMID: 38095068 Free PMC article. Review.
-
Induced pluripotent stem cell-derived smooth muscle cells increase angiogenesis and accelerate diabetic wound healing.Regen Med. 2020 Feb;15(2):1277-1293. doi: 10.2217/rme-2019-0086. Epub 2020 Mar 31. Regen Med. 2020. PMID: 32228292 Free PMC article.
References
-
- Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion and incorporation into vascular structures. Circulation. 2002;106:2781–2786. doi: 10.1161/01.CIR.0000039526.42991.93. - DOI - PubMed
-
- Georgiadis GS, Georgakarakos EI, Antoniou GA, Panagoutsos S, Argyriou C, Mourvati E, Passadakis P, Lazarides MK. Correlation of pre-existing radial artery macrocalcifications with late patency of primary radiocephalic fistulas in diabetic hemodialysis patients. J Vasc Surg. 2014;60:462–470. doi: 10.1016/j.jvs.2014.02.042. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources